Danny Hsu Shares The ”I-WISh” Study by Nichola Cooper on ITP
Danny Hsu, President of THANZ, reposted from ITP Australia and New Zealand on LinkedIn:
”Burden of disease in ITP patients is more significant than we think!
Thanks to the I-WISh study by Nichola Cooper, an excellent insight into what ITP patients go through.”
Quoting ITP Australia and New Zealand‘s post:
”Fatigue in ITP: A symptom that demands attention.
The original I‑WISh study highlighted a critical gap: while patients consistently report fatigue as one of the most disruptive aspects of Immune Thrombocytopenia (ITP), it is often under‑recognised in clinical practice.
“Fatigue has impacted my work, relationships, and daily routine.”
Now, I‑WISh 2.0 results are being finalised — with Australia included — offering fresh insights into patient and physician perspectives worldwide.
For healthcare professionals, this is a call to action: fatigue is not secondary.
It is central to the patient experience and must be addressed with empathy and integrated care strategies.
Explore the findings.”
Stay updated on all scientific advances with Hemostasis Today.
-
May 11, 2026, 14:44World Thalassaemia Day: Building Care Around Patients – Novo Nordisk Haemophilia and Haemoglobinopathies Foundation
-
May 11, 2026, 14:43Arun Rajasekaran: Demonstrating an Association Between Serum Anti-PLA2R Ab and Thrombosis Risk
-
May 11, 2026, 14:42Julie Makani: WHO 2026 Guidelines on the Management of Childhood Illness for SCD
-
May 11, 2026, 14:41Rikke Johannessen: Acknowledging Africa CDC Leadership in Advancing Africa’s NCD Agenda
-
May 11, 2026, 14:41Ahmed Alanazi: Understanding the Causes of Hypercoagulation
-
May 11, 2026, 14:40Katerina Pavenski: What Should Be the Future Priorities in PBM
-
May 11, 2026, 14:18Maria Cherska: The Future of Familial Hypercholesterolemia Care
-
May 11, 2026, 13:59Dino Mehic: What Clinicians May Overlook in Bleeding Disorders
-
May 11, 2026, 13:48Ney Carter Borges: POAF and Long-Term Outcomes After Cardiac Surgery